What is the recommended acyclovir dosing regimen for treating herpes simplex virus (HSV) or varicella‑zoster virus (VZV) uveitis in adults, including adjustments for renal impairment?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 17, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Acyclovir for Uveitis

For HSV or VZV uveitis in adults, treat with oral acyclovir 800 mg five times daily for 7 days, or alternatively valacyclovir 1000 mg every 8 hours for 7 days, with dose adjustment required for renal impairment.

Treatment Regimen

HSV Uveitis

For HSV-associated anterior uveitis, the standard oral antiviral options are 1:

  • Acyclovir: 200-400 mg five times daily
  • Valacyclovir: 500 mg two to three times daily
  • Famciclovir: 250 mg twice daily

However, most experts prefer valacyclovir due to simpler dosing schedules 2.

VZV Uveitis (Including Herpes Zoster Ophthalmicus)

For VZV-associated uveitis or ocular complications, higher doses are required because VZV is less sensitive to acyclovir than HSV 3, 4:

  • Acyclovir: 800 mg five times daily for 7 days 1
  • Valacyclovir: 1000 mg every 8 hours for 7 days 1
  • Famciclovir: 500 mg three times daily for 7 days 1

Treatment must be initiated within 72 hours of symptom onset for maximum efficacy, ideally within 48 hours 5.

Renal Dose Adjustment

Critical caveat: Acyclovir is eliminated primarily by the kidneys through glomerular filtration and tubular secretion 5, 6. Dose reduction is mandatory in patients with impaired renal function 5, 7.

  • Maintain adequate hydration during treatment 5
  • Monitor for reversible renal dysfunction and CNS symptoms 5
  • Avoid concurrent nephrotoxic agents 5
  • Elderly patients require particular attention as they have higher plasma concentrations due to age-related renal decline 5

Adjunctive Management

Topical Corticosteroids

  • Use judiciously for controlling intraocular inflammation
  • Avoid in HSV epithelial disease as corticosteroids potentiate HSV epithelial infections 1
  • Taper to minimum effective dose once inflammation is controlled 1
  • Monitor intraocular pressure (IOP) regularly during use 1

Glaucoma Management

  • VZV uveitis commonly causes trabeculitis-induced glaucoma 4
  • Use topical beta-blockers if IOP elevation occurs 2
  • Resolution of inflammation and normalization of IOP are treatment endpoints 2

Chronic or Recurrent Disease

For patients with chronic disease or frequent recurrences:

  • Prolonged treatment may be required with dose adjustment based on clinical response 1
  • Long-term prophylaxis with lower doses of oral antivirals should be considered 1
  • Immunocompromised patients need more aggressive treatment 1

Important Clinical Pearls

Diagnostic features highly specific for HSV/VZV uveitis 2:

  • Unilaterality
  • Elevated IOP
  • Decreased corneal sensation
  • Diffuse or sectoral iris atrophy (sectoral atrophy particularly characteristic of HSV)

Complications to monitor 4:

  • Iris atrophy
  • Complicated cataract
  • Neurotrophic keratopathy
  • Optic nerve involvement
  • In severe cases: acute retinal necrosis (immunocompetent) or progressive outer retinal necrosis (immunosuppressed)

Follow-up: Patients should be re-evaluated within 1 week, including visual acuity measurement, IOP check, and slit-lamp biomicroscopy 1.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.